Skip to content

Harmony Biosciences Holdings, Inc. HRMY Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$210.7M+203%
Alkermes logo
AlkermesALKS
-$67.29M-393%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$50.66M-145%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$63.74M+12.5%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$103.85M-61.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
Harmony Biosciences Holdings, Inc. (HRMY) reported comprehensive income (loss), net of tax, attributable to parent of $31.73M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 30.6% year-over-year, from $45.74M to $31.73M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 46.4% compound annual growth rate (CAGR), from $34.6M to $158.97M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This metric reflects the total change in equity from non-owner sources, encompassing net income and other gains or losses that are not yet realized or recognized in the standard income statement. It serves as a comprehensive measure of the company's financial performance by accounting for items like foreign currency translation adjustments or unrealized gains on securities. Monitoring this figure helps investors understand the broader economic impact on shareholder value beyond traditional operating profitability.